Smith & Nephew plc 2.7% Potential Decrease Indicated by JP Morgan Cazenove

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

Smith & Nephew plc with EPIC/TICKER (LON:SN) had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘NEUTRAL’ today by analysts at JP Morgan Cazenove. Smith & Nephew plc are listed in the Health Care sector within UK Main Market. JP Morgan Cazenove have set a target price of 1926 GBX on its stock. This would indicate that the analyst believes there is a downside of -2.7% from today’s opening price of 1979.5 GBX. Over the last 30 and 90 trading days the company share price has increased 83 points and increased 272 points respectively. The 1 year high stock price is 2023 GBX while the year low share price is currently 1417 GBX.

Smith & Nephew plc has a 50 day moving average of 1,870.11 GBX and a 200 Day Moving Average share price is recorded at 1,813.10. There are currently 875,195,533 shares in issue with the average daily volume traded being 1,914,006. Market capitalisation for LON:SN is £17,060,501,250 GBP.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
    Smith & Nephew's Q3 2024 update shows a 4% revenue growth to $1,412M. Despite China headwinds, US Orthopaedics and Sports Medicine excelled.
    Smith & Nephew plc (LON:SN, NYSE:SNN) reports a robust financial performance for Q2 and H1 2024, showing significant revenue and profit growth.
    Smith+Nephew plc (LON:SN, NYSE:SNN) reports Q1 revenue of $1,386 million, up 2.9% underlying. Orthopaedics and Sports Medicine show strong growth. CEO confident in outlook.
    Smith+Nephew plc reports solid financial results for Q4 and full year 2023, showcasing growth in revenue and profit margins. Analyst call scheduled for 27 Feb 2024.
    Smith+Nephew plc (LON:SN, NYSE:SNN) will be attending AAOS 2024 Annual Meeting to showcase its innovative medical technology solutions in San Francisco. Learn about their latest products and updates in the orthopaedic field.

      Search

      Search